GALT (Galectin Therapeutics Inc.) Stock Market Reviews

crown

search

Read and share opinions on GALT (Galectin Therapeutics Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

GALT

Galectin Therapeutics Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update
Nov 14, 2025
Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025
Oct 7, 2025
Galectin Therapeutics Inc. (GALT) Surges on Promising Belapectin Trial Data and Strong Financials
Sep 23, 2025
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Sep 2, 2025
Galectin Therapeutics Inc.'s (NASDAQ:GALT) top owners are individual investors with 54% stake, while 21% is held by insiders
Aug 15, 2025
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update
Aug 14, 2025
Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026
Jul 9, 2025
Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension
Jun 10, 2025
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update
May 15, 2025
Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress
Apr 15, 2025
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
Apr 7, 2025
Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update
Mar 31, 2025
Galectin Therapeutics to Present at the 2025 MASH-TAG Conference
Jan 10, 2025
Here's Why Galectin Therapeutics (GALT) is Poised for a Turnaround After Losing -31.83% in 4 Weeks
Dec 9, 2024

Reviews